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Dysmorphic features and developmental
delayWedescribe a female patient of 1 year and 5 months-old, referred for genetic evaluation due to neuropsychomotor
delay, hearing impairment and dysmorphic features. The patient presents a partial chromosome 21 monosomy
(q11.2→q21.3) in combination with a chromosome 3p terminal monosomy (p25.3→pter) due to an unbalanced
de novo translocation. The translocation was conﬁrmed by ﬂuorescence in situ hybridization (FISH) and the
breakpoints were mapped with high resolution array. After the combined analyses with these techniques the ﬁnal
karyotype was deﬁned as 45,XX,der(3)t(3;21)(p25.3;q21.3)dn,-21.ish der(3)t(3;21)(RP11-329A2-,RP11-439F4-,
RP11-95E11-,CTB-63H24+).arr 3p26.3p25.3(35,333-10,888,738))×1,21q11.2q21.3(13,354,643-27,357,765)×1.
Analysis of microsatellite DNA markers pointed to a paternal origin for the chromosome rearrangement. This
is the ﬁrst case described with a partial proximal monosomy 21 combined with a 3p terminal monosomy due
to a de novo unbalanced translocation.
© 2012 Elsevier B.V. Open access under the Elsevier OA license.1. Introduction
Partial deletion of chromosome 21 is a rare condition that has
been associated with dysmorphic features, heart defects, seizures, de-
layed motor function and mental retardation. Proximal 21q deletions
often occur with segmental aneuploidy of other chromosomes, a con-
dition that makes the precise identiﬁcation of segments involved dif-
ﬁcult (Lindstrand et al., 2010; Riegel et al., 2005). Full monosomy 21
is probably not compatible with life, and some reports that have
been published without molecular conﬁrmation most likely represent
cryptic unbalanced translocations or mosaics (Riegel et al., 2005).
Rare cases of complete monosomy 21 prenatally diagnosed that sur-
vived to term were followed by early neonatal death (Mori et al.,
2004). There is not a recognized facial phenotype associated within situ hybridization; BERA,
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vier OA license.21 monosomy (Keren et al., 2007). By the other way, 3p terminal
deletions are related to variable clinical features (Malmgren et al.,
2007).
Herewe describe a female patient carrying a partial chromosome 21
monosomy (q11.2→q21.3) in combination with a chromosome 3p ter-
minal monosomy (p25.3→pter) due to an unbalanced translocation.
2. Clinical report
The proband is a 1 year and 5 months-old girl, referred for genetic
evaluation for neuropsychomotor delay, hearing impairment and
dysmorphic features. She is the second daughter born from non-
consanguineous parents (father — 39 years old / mother — 29 years
old). Family history revealed a maternal half-sister and a maternal
half-brother apparently healthy, and a maternal aunt with hearing
loss and absence of language (not examined). Pregnancy was un-
eventful. She was delivered at term by cesarean section; her birth
weight was 2240 g (below the third centile), birth length was
41 cm (below the third centile) and head circumference was 31 cm
(also below the third centile). During her ﬁrst year of life, she showed
developmental delay and failure to thrive.
Upon evaluation her weight was 6700 g (below the third centile
and corresponding to 5 months of age), length was 68 cm (below
the third centile and corresponding to 7.5 months of age), and head
circumference was 40 cm (also below the third centile and corre-
sponding to 3 months of age), denoting an important failure to thrive.
Fig. 1. A): Patient's picture showing facial dysmorphisms, including arched eyebrows with medial ﬂare, up-slanting palpebral ﬁssures, blepharophimosis, bilateral ptosis, wide and
depressed nasal bridge, bulbous tip of nose, anteverted nostrils, down-turned corners of the mouth and thin lips. B): Picture of patient's hands showing spindle-shaped ﬁngers, mild
lymphedema of hands and mildly dorsiﬂexed great toes.
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occiput, bi-temporal narrowing, wide anterior fontanelle, low poste-
rior hairline, bilateral pre-auricular pits, arched eyebrows with medi-
al ﬂare, up-slanting palpebral ﬁssures, blepharophimosis, bilateral
ptosis, hypertelorism, wide and depressed nasal bridge, bulbous tip
of nose, anteverted nostrils, down-turned corners of the mouth, thin
lips, long and smooth philtrum, mild retrognathia, wide hands with
spindle-shaped ﬁngers, bilateral incomplete palmar creases, mild
lymphedema of hands and feet, mildly dorsiﬂexed great toes and sa-
cral dimple (Fig. 1) (Supplementary Fig. 1).
During evaluation, ophthalmologic examination, lumbosacral
X-ray, transfontanellar ultrasound, abdominal ultrasound and echo-
cardiogram disclosed no alterations. Brainstem Evoked Response
Audiometry (BERA) showedmoderate hearing loss in both ears, though
not suggestive of cochlear nerve and auditory pathways involvement.
Serum exams – TSH (thyroid stimulating hormone), FSH (follicle stim-
ulating hormone), FT4 (free thyroxine), 17-OH-progesterone (17alpha-
hydroxyprogesterone), LH (luteinizing hormone), free and conjugated
testosterone values –were within normal limits.3. Methods and results
3.1. Cytogenetics and FISH
The karyotype analysis of the patient revealed a missing chromo-
some 21 and an additional segment on the short arm of chromosome
3 in 50 analyzedmetaphases (Fig. 2A). The karyotypes of both parents
were normal.
FISH was performed using BAC clones as previously described
(Freitas et al., 2011). A subtelomere probe for the long arm of chro-
mosome 21 (CTB-63H24 - 21q22.3-47943440-48100495 — assembly
GRCh37) was used and conﬁrmed the presence of material from chro-
mosome 21 on the derivative chromosome 3 (Fig. 2B). Additional BAC
probes were used (RP11-329A2, RP11-439F4 and RP11-95E11 mapped
at 3p; RP11-102E10, RP11-410P24 and RP11-132H24 mapped at 21q),
which conﬁrmed the rearrangement and revealed 3p terminal and
21q proximal deletions (data not shown).3.2. Array and microsatellite DNA marker analyses
High resolution array was performed using the Genome-Wide
Human SNP Array 6.0 (Affymetrix®, Santa Clara, CA, USA) accordingto manufacturer's instructions. Data were analyzed by the Affymetrix
Genotyping console 4.0 software (Affymetrix®, Santa Clara, CA, USA).
Array analysis showed a deletion from 3p25.3 to 3p26.3 region with
approximately 10.8 Mb (breakpoints: 35,333-10,888,738 bp- NCBI Build
36.1 [hg18]) (Fig. 3A) and a deletion from 21q11.2 to 21q21.3 region
with approximately 14.0 Mb (break points: 13,354,643-27,357,765 bp
(NCBI Build 36.1 [hg18]) (Fig. 3B). The ﬁnal karyotype was deﬁned as
follow: 45,XX,der(3)t(3;21)(p25.3;q21.3)dn,-21.ish der(3)t(3;21)
(RP11-329A2-,RP11-439F4-,RP11-95E11-,CTB-63H24+).arr
3p26.3p25.3(35,333-10,888,738)×1,21q11.
2q21.3(13,354,643-27,357,765)×1.
Analysis of microsatellite DNA markers was performed by auto-
matic genotyping. Markers mapped inside the deleted regions
(D3S1297, D3S1304 and D21S1256) were selected from ABIPRISM
Linkage Mapping set v. 2.5-HD5 (Applied Biosystems®). Genotyping
was performed by polymerase chain reaction and products were
subsequently separated by capillary electrophoresis on Applied
Biosystems 3500xl Genetic Analyzer® (Applied Biosystems®). The
marker D21S1256 was uninformative. Loss of heterozygosity was
found for markers D3S1297 and D3S1304 of chromosome 3 (data
not shown). Only the maternal allele was observed in the proband,
pointing to a paternal origin for the chromosome rearrangement.4. Discussion
To date, at least 15 cases of unbalanced translocations giving rise
to partial monosomy 21 have been reported involving different chro-
mosomes such as 4, 5, 7, 11, 17, 18 and X (Cardoso et al., 2008;
Hannachi et al., 2011; Riegel et al., 2001, 2005; Vorsanova et al.,
2008). To our knowledge this is the ﬁrst case described with a partial
monosomy 21 combined with 3p monosomy due to a de novo unbal-
anced translocation.
A probable mechanism of origin for this rearrangement could be a
reciprocal translocation followed by 3:1 segregation during meiosis.
This mechanism is named 3:1 segregation with tertiary monosomy,
which is fairly uncommon – at least in a term pregnancy – and may
arise only if one derivative is very small, and the amount of material
that is missing is “monosomically small” (Gardner et al., 2012). In
the case presented here only 3p distal and 21q proximal segments
are missing.
The parental origin of the translocation in the present case was de-
termined to be paternal, which is in accordance with the literature
concerning structural chromosome rearrangements. The increased
Fig. 2. A): Partial karyotype showing the derivative chromosome 3 and a chromosome 21 monosomy. The arrow points to additional chromosome material on the short arm of
chromosome 3. B): FISH analysis on metaphase spreads with BAC CTB-63 H24 (21q22.3-47943440-48100495 — assembly GRCh37), showing one signal on a chromosome 21
and another signal on the derivative chromosome 3.
303A.P. Santos et al. / Gene 513 (2013) 301–304frequency of chromosomal breaks and/or the presence of acentric frag-
ments can be inﬂuenced by age inmen.However, the impact of paternal
age on gametogenesis is still not well understood (Templado et al.,
2011). In this family, the father is young and there is no history of risk
factors for abnormal gametogenesis.
Some authors suggested that the proximal half of 21q contains 58
genes and, as consequence, rearrangements involving this region are
possibly more tolerable than rearrangements involving distal regionFig. 3. A) Array proﬁle of chromosome 3. The circle highlights the 10.8 Mb deletion at p25.3
deletion at q11.2–>q21.3 region.(Cardoso et al., 2008; Hattori et al., 2000). Monosomy of chromosome
21, including APP (Amyloid Beta (A4) Precursor Protein) and SOD1
(Cu/Zn superoxide dismutase) genes, was previously described in a
patient with clinical features such as facial anomalies, hypertonia,
mental retardation and arthrogryposis (Hannachi et al., 2011). The
region deleted in our patient encompasses only APP gene.
Beyond 21q11.2→q21.3 deletion of approximately 14.0 Mb, the
patient here described also presents a deletion at 3p25.3→p26.3–>p26.3 region. B) Array proﬁle of chromosome 21. The circle highlights the 14.0 Mb
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3p25–3p26 are related to variable clinical features such as developmen-
tal and growth delay, multiple dysmorphisms, telecanthus, ptosis, men-
tal retardation, micrognathia, micro-and brachycephaly, hypertelorism,
low ears, postaxial polydactyly, renal anomalies, cleft palate, congenital
heart defects and gastrointestinal anomalies (Cuoco et al., 2011; Dundar
et al., 2010; Gijsbers et al., 2010). Keren et al. (2007) reported two
unrelated cases with similar partial 21q proximal deletion with
mild characteristic facial appearance. Considering this, we suggested
that 3p25.3 terminal deletion is mainly responsible for the facial
dysmorphisms in our patient.
The 3pter region deleted in our patient involves several know genes
(CHL1, CNTN6, CNTN4, IL5RA, CRBN, TRNT1, LRRN1, SUMF1, SETMAR,
ITPR1, BHLHE40, ARL8B, EDEM1, GRM7, LMCD1, CAV3, OXTR, RAD18,
SRGAP3, THUMPD3, SETD5, LHFPL4, MTMR14, CPNE9, BRPF1, OGG1,
CAMK1, TADA3L, ARPC4, TTLL3, RPUSD3, CIDEC, JAGN1). Some of these
were described in one case of 3p deletion (Gunnarsson and Foyn
Bruun, 2010) where the genes SRGAP3 (SLIT-ROBO Rho GTPase activat-
ing protein 3), CNTN4 (contactin 4), CHL1 (cell adhesion molecule with
homology to L1CAM) and CRBN (cereblon) have been suggested as re-
sponsible for developmental delay or mental retardation.
Endris et al. (2002) reported one patient with mental retardation
and a balanced de novo translocation t(X;3)(p11.2;p25) in which chro-
mosome 3 breakpoint interrupts SRGAP3 gene (Endris et al., 2002). This
gene is predominantly expressed in fetal and adult brain, speciﬁcally in
the neurons of the hippocampus and cortex, structures known to play a
pivotal role in higher cognitive function, learning, and memory. There-
fore, authors suggest that haploinsufﬁciency of this gene may lead to
abnormal development of neural structures. Findings reported by
Shuib et al. (2009) were consistent with the hypothesis that SRGAP3 is
a prime candidate for psychomotor retardation in 3pter deletion
(Shuib et al., 2009).
CNTN4 gene, a member of a protein family that has been shown to
be involved in axon growth, guidance, and fasciculation (Kamei et al.,
2000) encodes a neuronal adhesion molecule and has been proposed
to have a function in synaptic plasticity (Murai et al., 2002). Deletion
or disruption of CNTN4 was previously described in 3pter deletion
patients with developmental delay and mental retardation (Fernandez
et al., 2004, 2008).
Another gene located at 3p26.3 that has been suggested to contrib-
ute to mental development is CHL1 (Frints et al., 2003; Shrimpton et
al., 2006), which is a member of L1 neuronal cell adhesion molecules
family. The haploinsufﬁciency of only this gene was reported in a boy
with mental retardation (Gardner et al., 2012), while deletion at 3pter
encompassing CHL1, CNTN4, and CRBN genes was reported to cause
more severe phenotypes (Dijkhuizen et al., 2006; Pohjola et al., 2010).
Sensorineural hearing loss is presented in some of the reported
cases and is probably caused by haploinsufﬁciency of ATP2B2 gene
(ATPase Ca+2 transporting plasma membrane 2) located at 3p25.3
(Dundar et al., 2010; McCullough et al., 2007). The patient herein de-
scribed presents moderate hearing loss, but not neurosensorial type.
Therefore, this ﬁnding probably is associated with conductive causes.
This report documents a rare unbalanced chromosomal transloca-
tion that caused partial monosomies 3p and 21q simultaneously.
Once again the importance of using different cytogenetic and molec-
ular techniques to clarify unusual karyotypes was demonstrated.
Supplementary data to this article can be found online at http://
dx.doi.org/10.1016/j.gene.2012.09.008.Acknowledgments
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